Michael Petusky

Stock Analyst at Barrington Research

(0)
# 4444
Out of 5,329 analysts
195
Total ratings
29.45%
Success rate
-14.54%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
OPK OPKO Health
Maintains: Outperform
3 3
1.34 67.91% 12 May 1, 2025
OPCH Option Care Health
Maintains: Outperform
38 38
32.16 18.16% 15 Apr 30, 2025
MMSI Merit Medical System...
Maintains: Outperform
111 103
93.28 10.42% 20 Apr 25, 2025
ANIK Anika Therapeutics
Maintains: Outperform
25 20
14.52 37.74% 16 Mar 13, 2025
VRME VerifyMe
Maintains: Outperform
2 2
0.72 73.61% 9 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 6
1.4 328.57% 14 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 20
13.93 43.58% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 98
71.44 37.18% 22 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 9 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 90
64.51 39.51% 13 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 95
63.08 50.6% 23 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
n/a n/a 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016